📊 SBCWW Key Takeaways
Is SBC Medical Group Holdings Inc (SBCWW) a Good Investment?
SBC Medical exhibits fortress-like financial health with exceptional profitability (29.4% net margin), minimal debt (0.17x D/E ratio), and strong cash generation. However, a significant 15.5% YoY revenue decline coupled with flat net income signals deteriorating growth momentum that warrants caution despite operational excellence.
SBC Medical Group Holdings Inc Key Strengths (SBCWW)
- Exceptional profitability with 29.4% net margin and 38.9% operating margin
- Fortress balance sheet with $163.8M cash, 3.78x current ratio, and minimal leverage (0.17x D/E)
- Strong returns with 20.5% ROE and 13.4% ROA demonstrating efficient capital deployment
- Positive free cash flow generation of $23.3M with low capital intensity (1.4M CapEx)
SBCWW Stock Risks: SBC Medical Group Holdings Inc Investment Risks
- Revenue declined 15.5% YoY - significant top-line deterioration indicating market share loss or demand reduction
- Net income essentially flat despite revenue decline suggests limited growth pathway without further cost-cutting
- Medical services sector exposure to regulatory changes, reimbursement rate pressures, and provider competition
- Minimal insider activity (1 Form 4 in 90 days) suggests limited insider confidence
Key Metrics to Watch
- Quarterly revenue trend to confirm stabilization or continued decline
- Patient volume and average revenue per patient to diagnose revenue pressure source
- Operating margin sustainability as cost-cutting capacity becomes exhausted
SBC Medical Group Holdings Inc (SBCWW) Financial Metrics & Key Ratios
💡 AI Analyst Insight
Strong liquidity with a 3.78x current ratio provides a solid financial cushion.
SBCWW Profit Margin, ROE & Profitability Analysis
SBCWW vs Services Sector: How SBC Medical Group Holdings Inc Compares
How SBC Medical Group Holdings Inc compares to Services sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is SBC Medical Group Holdings Inc Stock Overvalued? SBCWW Valuation Analysis 2026
Based on fundamental analysis, SBC Medical Group Holdings Inc appears fundamentally strong relative to the Services sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
SBC Medical Group Holdings Inc Balance Sheet: SBCWW Debt, Cash & Liquidity
SBCWW Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: SBC Medical Group Holdings Inc's revenue has remained relatively flat over the 5-year period, with a 0% decline. The most recent EPS of $0.48 reflects profitable operations.
SBCWW Revenue Growth, EPS Growth & YoY Performance
SBCWW Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $43.1M | $11.3M | $0.11 |
| Q3 2025 | $43.4M | $2.8M | $0.03 |
| Q2 2025 | $43.4M | $2.5M | $0.02 |
| Q1 2025 | $47.3M | $18.8M | $0.20 |
| Q3 2024 | $47.3M | $2.8M | $0.03 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
SBC Medical Group Holdings Inc Dividends, Buybacks & Capital Allocation
SBCWW SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for SBC Medical Group Holdings Inc (CIK: 0001930313)
📋 Recent SEC Filings
❓ Frequently Asked Questions about SBCWW
What is the AI rating for SBCWW?
SBC Medical Group Holdings Inc (SBCWW) has an AI grade of B with 70% confidence, based on fundamental analysis of SEC EDGAR filings.
What are SBCWW's key strengths?
Claude: Exceptional profitability with 29.4% net margin and 38.9% operating margin. Fortress balance sheet with $163.8M cash, 3.78x current ratio, and minimal leverage (0.17x D/E).
What are the risks of investing in SBCWW?
Claude: Revenue declined 15.5% YoY - significant top-line deterioration indicating market share loss or demand reduction. Net income essentially flat despite revenue decline suggests limited growth pathway without further cost-cutting.
What is SBCWW's revenue and growth?
SBC Medical Group Holdings Inc reported revenue of $173.6M.
Does SBCWW pay dividends?
SBC Medical Group Holdings Inc does not currently pay dividends.
Where can I find SBCWW SEC filings?
Official SEC filings for SBC Medical Group Holdings Inc (CIK: 0001930313) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is SBCWW's EPS?
SBC Medical Group Holdings Inc has a diluted EPS of $0.50.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined grade reflects both perspectives for balanced insights.
What is SBCWW's fundamental grade?
Based on our AI fundamental analysis in May 2026, SBC Medical Group Holdings Inc has a B grade with 70% confidence. Review the strengths and risks sections above for full context. This is not investment advice.
Is SBCWW stock overvalued or undervalued?
Valuation metrics for SBCWW: ROE of 20.5% (sector avg: 16%), net margin of 29.4% (sector avg: 10%). Higher ROE suggests strong returns relative to peers.
What is SBCWW's AI grade for 2026?
Our dual AI analysis gives SBC Medical Group Holdings Inc a combined B grade for 2026. Revenue is data pending, with profitability above sector average. Always conduct your own research.
What is SBCWW's free cash flow?
SBC Medical Group Holdings Inc's operating cash flow is $24.7M, with capital expenditures of $1.4M. FCF margin is 13.4%.
How does SBCWW compare to other Services stocks?
Vs Services sector averages: Net margin 29.4% (avg: 10%), ROE 20.5% (avg: 16%), current ratio 3.78 (avg: 1.5).